pharmaceutical investing Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance 04 August
pharmaceutical investing Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo 30 July
pharmaceutical investing European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union 29 July
